Ă…tomic-level precision medicine to fight bacterial infections

Our company is developing new medicines against the world’s most deadly bacteria.

Bacteria are now known to cause diseases like stomach ulcers and cancer, and are implicated in inflammatory bowel diseases such as Crohn’s and Ulcerative Colitis.

Every year, billions become infected and millions die worldwide.

Current antibiotics are increasingly ineffective to treat infections by Pseudomonas, Salmonella, E. coli, and Helicobacter.

Amethyst is developing new strategies to specifically target and kill bacteria.

Our therapies are designed to inhibit essential bacterial lifelines to assist our immune system in clearing infections.

We use Nobel Prize-winning technology to examine drug targets and develop unique drug leads that function through high specificity to reduce toxic side effects and prevent antibiotic resistance development.

Join us today and help us toward our goal of eradicating bacterial infections.